Dr. Miver Erem Tokuş
NeurosurgeryVerified
- 24+years exp.
English · Turkish
60 seconds · no obligationView Profile
What a spinal cord stimulator (SCS) is, how the two-stage trial and permanent implant deliver electrical pulses to the dorsal columns, what clinical evidence says about pain reduction in failed back surgery syndrome and CRPS, approximate costs in Turkey compared with the UK, US and Germany, realistic pain relief expectations, recovery milestones, complications and how to choose a qualified neurosurgical centre.
A written plan with the surgeon's name and the full price — usually within 24 hours.

1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
NeurosurgeryVerified
English · Turkish
60 seconds · no obligationView Profile
A spinal cord stimulator (scs) is an implantable neuromodulation system for severe, chronic neuropathic pain that has not responded to medication, physical therapy or corrective spinal surgery. Based on the gate control theory of pain, the device positions thin insulated electrode leads into the epidural space along the dorsal columns of the spinal cord, connected to a battery unit called an implantable pulse generator (IPG). The leads emit mild electrical pulses that intercept pain signals travelling to the brain. Because the system is reversible, it can be turned off or removed without altering spinal anatomy. For an overview of cranial and spine procedures, see our guide to neurosurgery treatments in Turkey.
Modern neuromodulation offers high-frequency 10 kHz therapy and burst stimulation that relieve pain without tingling (paraesthesia). Patients exploring a spinal cord stimulator (scs) in Turkey undergo a two-stage pathway: a temporary trial to confirm pain relief, followed by permanent implantation only when results are verified. When researching spinal cord stimulator (scs) Turkey options, verifying hospital accreditation and neurosurgical credentials ensures safe care.
Spinal cord stimulation is unique because candidates test therapy before committing to a permanent device. In the percutaneous trial, lasting three to seven days, a neurosurgeon introduces flexible leads into the epidural space under local anaesthesia with mild sedation, guided by real-time fluoroscopic X-ray. The leads connect to an external battery worn on a belt. During this trial period, you assess pain relief and mobility in your daily routine using a handheld controller to adjust settings.
If the trial delivers 50% or greater pain relief, permanent implantation follows under general anaesthesia or deep sedation. The surgeon secures permanent cylindrical or paddle leads to the supraspinous ligament, tunnels lead extensions under the skin to a subcutaneous pocket in the buttock or abdomen, seats the pulse generator and closes the incisions in layers before wireless programming.
Clinical trials and public health bodies, including the UK National Institute for Health and Care Excellence (NICE), confirm that spinal cord stimulation relieves chronic neuropathic pain in failed back surgery syndrome (persistent spinal pain syndrome type 2), complex regional pain syndrome (CRPS) and painful diabetic neuropathy. Between 50% and 70% of carefully selected patients achieve at least 50% pain relief alongside reduced medication reliance.
However, SCS does not treat mechanical axial back pain, disc degeneration or fibromyalgia. Evidence shows success depends on rigorous candidate selection, psychological screening and a positive trial. NICE guidelines recommend spinal cord stimulation as a cost-effective, evidence-based alternative to repeated open spine surgeries or escalating opioid doses for intractable chronic nerve pain. Like other functional neurosurgical procedures such as surgical treatment of epilepsy, stimulation modifies neural signalling rather than correcting spinal anatomy.
Costs reflect advanced pulse generator hardware, surgical theatre time and specialist neurosurgical care. The figures below are approximate self-pay ranges covering both trial and permanent implantation, not hospital-specific quotes.
| Country | Approximate cost range |
|---|---|
| Turkey | €14,000 – €26,000 |
| United Kingdom | €26,000 – €48,000 |
| United States | €38,000 – €80,000 |
| Germany | €24,000 – €44,000 |
Factors influencing the spinal cord stimulator (scs) cost and final spinal cord stimulator (scs) price include battery type: rechargeable units cost more initially but last 10 to 25 years, whereas non-rechargeable units require replacement after three to five years. Surgical paddle leads requiring laminotomy also take longer theatre time than percutaneous leads.
An international package in Turkey normally includes pre-operative tests, surgeon and anaesthetist fees, trial leads, permanent IPG hardware, hospital nights, programming sessions and transfers. You can request a review via our free quote page.
Neuromodulation options address different patterns of chronic intractable pain. The table below compares the primary modalities.
| Method | Best suited to | Typical limits |
|---|---|---|
| Spinal cord stimulator (SCS) | Failed back surgery syndrome, radiating leg pain (radiculopathy), CRPS | Less effective for isolated axial back pain or focal groin/foot pain |
| Dorsal root ganglion (DRG) stimulation | Focal neuropathic pain in the groin, knee, foot or pelvic region | Technically demanding lead placement targeted to discrete sensory ganglia |
| Intrathecal drug delivery pump | Widespread cancer pain, severe axial spine pain or severe muscle spasticity | Requires routine medication refills and carries catheter or pump-fill risks |
Spinal cord stimulation remains the standard choice for broad back and lower-limb neuropathic pain. DRG stimulation targets isolated nerve root pain, while intrathecal pumps deliver targeted medication into cerebrospinal fluid when electrical neuromodulation is unsuitable.
Good candidates are adults with chronic neuropathic back, leg or arm pain lasting over six months that has not responded to conservative therapies, nerve blocks or spinal decompression. Candidates must have an identifiable nerve pathology, a positive trial achieving over 50% relief, and a psychological assessment confirming realistic expectations and healthy coping mechanisms.
You are less suited if you have active systemic or local infections, untreated severe depression or substance dependence, severe bleeding disorders or severe spinal canal stenosis obstructing the epidural space. Inability to manage the remote programmer or recharging equipment is also a contraindication. Patients needing non-compatible MRIs must ensure an MRI-conditional device is used.
An SCS implant modulates pain transmission; it does not cure structural spinal damage or eliminate pain entirely. Clinical success is defined as a 50% or greater reduction in daily pain intensity. For most patients, this means improved sleep, greater walking tolerance and a reduced need for heavy prescription painkillers, helping to clear cognitive fog.
There are no aesthetic before-and-after photographs; functional outcomes appear in restored daily independence. While stimulation significantly dampens neuropathic pain, patients should still expect occasional minor fluctuations related to weather, stress or physical fatigue. Incision scars are modest: a 3–5 cm line along the spine and a 5–7 cm line over the battery pocket, forming a slight contour under the skin that is invisible beneath clothing. Device programming is fine-tuned periodically over time.
Patients undergoing spinal cord stimulator (scs) recovery generally spend 10 to 14 days in Turkey when scheduling the trial and permanent implant within one trip. This allows time for consultation, trial lead placement, testing, permanent surgery, hospital recovery, programming and wound review before flying.
During the first six to eight weeks, fibrous tissue encapsulates the leads. To prevent lead migration, you must avoid bending, twisting, stretching overhead and lifting objects over 2.5 kg. Desk work typically resumes after two to three weeks, with gentle walking encouraged daily. Request airport assistance when travelling home to avoid carrying heavy cabin baggage or straining your surgical incisions. Read about how it works when planning travel and recuperation schedules.
Spinal cord stimulation is an established, reversible therapy, but it involves surgical risks. According to the FDA and professional neuromodulation guidelines, hardware complications are the primary reason for revision. Lead migration occurs in roughly 5% to 10% of cases, requiring lead repositioning if stimulation coverage is lost. Lead fracture or battery malfunction can also occur.
Biological risks include surgical site infection (2% to 5%), which may necessitate system explantation if antibiotics fail. Dural puncture during epidural entry occurs in 1% to 2% of procedures, causing a temporary positional headache that responds to bed rest or a blood patch. Epidural haematoma and nerve irritation are rare when performed in specialised centres.
Ensure the procedure is performed by a board-certified neurosurgeon specialising in spine neuromodulation within an accredited tertiary hospital equipped with neuro-monitoring and laminar airflow theatres. Specialist centres offering neurosurgery treatments in Turkey provide multidisciplinary pain teams and clear trial protocols. Red flags include clinics that bypass the trial stage, guarantee 100% pain relief or conceal device brand names. Review how it works before submitting medical records.
Key questions to ask the clinic:
A spinal cord stimulator (SCS) is an implanted medical system consisting of thin electrical leads placed in the epidural space of the spine and a small battery generator under the skin. It sends mild electrical pulses to the spinal cord to interrupt chronic neuropathic pain signals before they reach the brain.
Yes, for properly selected patients with neuropathic conditions such as failed back surgery syndrome and complex regional pain syndrome. Clinical studies demonstrate that between 50% and 70% of patients achieve at least a 50% reduction in pain. A pre-implantation trial ensures the device works for you before a permanent implant is placed.
A spinal cord stimulator in Turkey typically costs between €14,000 and €26,000 for both the trial and permanent implant. In the UK, private treatment generally ranges from €26,000 to €48,000. The total price depends on whether you receive a rechargeable or non-rechargeable battery and the type of leads required.
Because SCS treats chronic internal nerve pain rather than cosmetic concerns, results are measured functionally. Patients typically experience significant pain relief, reduced dependence on prescription painkillers, improved sleep and greater walking endurance. Visually, surgery leaves only two small, discrete scars: one along the spine and another over the battery pocket.
Initial wound healing takes about two weeks, during which you must avoid bending, twisting or lifting objects heavier than 2.5 kg to prevent lead displacement. Most patients return to light desk work within two to three weeks, while full tissue healing and permanent lead anchoring take six to eight weeks.
Lead placement and pocket creation are performed under local anaesthesia with sedation or general anaesthesia, so you will not feel surgical pain during the procedure. Post-operative soreness at the incision sites is normal for several days and managed with standard analgesics. The electrical stimulation itself feels like gentle tingling or is imperceptible.
Non-rechargeable primary cell batteries typically last between three and five years before requiring a brief outpatient procedure to replace the generator. Rechargeable generators last between 10 and 25 years depending on the manufacturer, but they require periodic wireless recharging for an hour or two once or twice a week.
Spinal cord stimulation is widely regarded as a safe and reversible neuromodulation therapy approved by major health authorities like the FDA and NICE. The most common complications are hardware-related, such as lead migration or battery depletion. Serious complications like infection or dural puncture occur in a small percentage of cases.
Neither is universally superior; they address different pain profiles. Spinal cord stimulation uses electrical signals to manage neuropathic back and leg pain without medications. Intrathecal drug delivery pumps infuse liquid pain medication directly into spinal fluid, making them more appropriate for widespread cancer pain, severe axial pain or severe muscle spasticity.
If completing both the trial phase and permanent implantation in one journey, plan to stay in Turkey for 10 to 14 days. This schedule allows for pre-operative imaging, lead placement, a multi-day trial evaluation, permanent generator implantation, device programming and wound checks before travelling home.
Your request is in!
Your coordinator will contact you — usually within 2 hours, 24/7.
Want a faster, more accurate assessment?
Add photos & medical detailsLeave your number — a coordinator calls you in your language, usually within 15 minutes during office hours.
Thank you!
A coordinator will contact you at the time you chose.